Date published: 2026-5-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

CIITA Activators

The term CIITA Activators refers to a class of chemical compounds that possess the unique ability to interact with and modulate the activity of the class II major histocompatibility complex transactivator (CIITA). CIITA is a key transcriptional regulator in the immune system and plays a crucial role in the expression of major histocompatibility complex class II (MHC-II) genes. MHC-II molecules are essential for antigen presentation, a critical process in the adaptive immune response, where they display fragments of foreign proteins (antigens) to T cells, enabling the immune system to recognize and respond to pathogens. CIITA activators, therefore, are compounds that can influence the expression of MHC-II genes by modulating the activity of CIITA, thereby impacting the immune system's ability to recognize and respond to antigens.

The mechanism of action of CIITA activators typically involves their ability to enhance or inhibit the transcriptional activity of CIITA. This transcription factor regulates the expression of MHC-II genes by binding to their promoter regions and initiating their transcription. CIITA activators may interact with CIITA directly or with other regulatory proteins involved in the CIITA-mediated transcriptional pathway. By doing so, they can either enhance the expression of MHC-II genes, leading to increased antigen presentation, or inhibit CIITA's activity, reducing the presentation of antigens to T cells. Understanding the properties and effects of CIITA activators is fundamental in immunology research, as it sheds light on the regulation of antigen presentation and the intricate mechanisms that govern immune responses against pathogens and foreign substances.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol can enhance MHC class II expression, potentially influencing CIITA activity indirectly.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Quercetin impacts inflammatory pathways, potentially affecting CIITA-mediated gene expression.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin activates cAMP pathways, which might intersect with CIITA-regulated pathways.

Cholecalciferol

67-97-0sc-205630
sc-205630A
sc-205630B
1 g
5 g
10 g
$71.00
$163.00
$296.00
2
(1)

Cholecalciferol modulates immune responses, potentially affecting CIITA activity.

Butyric acid

107-92-6sc-214640
sc-214640A
1 kg
10 kg
$64.00
$177.00
(0)

Butyric acid, a histone deacetylase inhibitor, can influence gene expression, potentially affecting CIITA.

Pioglitazone

111025-46-8sc-202289
sc-202289A
1 mg
5 mg
$55.00
$125.00
13
(1)

Pioglitazone, a PPAR-gamma agonist, may indirectly influence CIITA activity through PPAR-gamma pathways.

Roflumilast

162401-32-3sc-208313
5 mg
$60.00
21
(1)

Roflumilast, a PDE4 inhibitor, may intersect with pathways involving CIITA.